Actively Recruiting
NeuroVision vs Standard Neuromonitoring
Led by Rush University Medical Center · Updated on 2026-04-07
148
Participants Needed
1
Research Sites
377 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to perform a prospective, randomized, controlled clinical trial to assess the utility of IONM in patients undergoing primary, single or multilevel lateral spinal procedures. Subjects will be randomized to undergo a lateral spine surgery with the use of NeuroVision® IONM or conventional hospital based IONM to assess incidence of new-onset neurological injury.
CONDITIONS
Official Title
NeuroVision vs Standard Neuromonitoring
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing a primary single or multilevel lateral spinal surgery procedures for degenerative pathology
- Diagnosis includes myelopathy, radiculopathy, myeloradiculopathy, central stenosis, foraminal stenosis, herniated nucleus pulposus, degenerative disc disease, spondylosis, and osteophytic complexes
- Patients able to provide informed consent
You will not qualify if you...
- Active infection
- Active or history of malignancy
- Spinal traumatic injury within the past 2 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rush University Medical Center
Chicago, Illinois, United States, 60612
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here